Hennig Branwen J, Fulford Anthony J, Sirugo Giorgio, Rayco-Solon Pura, Hattersley Andrew T, Frayling Timothy M, Prentice Andrew M
MRC International Nutrition Group, NPHIRU, EPH, London School of Hygiene & Tropical Medicine, London, UK.
BMC Med Genet. 2009 Mar 5;10:21. doi: 10.1186/1471-2350-10-21.
Variation in the fat mass and obesity associated (FTO) gene has been reproducibly associated with body mass index (BMI) and obesity in populations of White European origin. Data from Asians and African-Americans is less conclusive.
We assessed the effect of 16 FTO polymorphisms on body mass in a large population of predominantly lean Gambians (N(max) 2208) participating in a long-term surveillance program providing contemporary and early-life anthropometric measurements.
Sixteen FTO tagSNPs screened here, including several associated with BMI in Europeans, were not associated with birth weight (BWT), early weight gain in 1-2 year olds, BMI in adults (> or = 18 y), or weight-for-height (WFH) z-score across all ages. No association was seen between genotype and WFH z-score or other measures of body mass. The confidence limits indicate that the effect size for WFH z-score never exceeded 0.17 units per allele copy for any SNP (excluding the three SNPs with allele < 15%). with much the lowest allele frequency. The confidence interval of the effect size for rs9939609 did not overlap that reported previously in Europeans.
To our knowledge this is the first study of FTO gene variation in a well-characterised African population. Our results suggest that FTO gene variation does not influence measures of body mass in Gambians living a traditional lifestyle, or has a smaller effect than that detected in Europeans. These findings are not directly comparable to results from previous studies in African-Americans due to differences in study design and analysis. It is also possible that any effect of FTO genotype on body mass is of limited relevance in a lean population where little excess food is available, compared to similar ethnic populations where food supply is plentiful.
脂肪量和肥胖相关基因(FTO)的变异在欧洲白人血统人群中已被反复证实与体重指数(BMI)及肥胖相关。亚洲人和非裔美国人的数据则不太确凿。
我们在大量主要为瘦型的冈比亚人群(最多2208人)中评估了16个FTO基因多态性对体重的影响,这些人群参与了一项长期监测项目,该项目提供了当代及早期生活阶段的人体测量数据。
在此筛选的16个FTO标签单核苷酸多态性(tagSNP),包括一些在欧洲人与BMI相关的多态性,与出生体重(BWT)、1 - 2岁幼儿的早期体重增加、成年人(≥18岁)的BMI或各年龄段的身高体重比(WFH)z评分均无关联。未观察到基因型与WFH z评分或其他体重指标之间存在关联。置信区间表明,对于任何单核苷酸多态性,WFH z评分的效应大小每个等位基因拷贝从未超过0.17单位(不包括等位基因频率<15%的三个单核苷酸多态性,其等位基因频率最低)。rs9939609效应大小的置信区间与先前在欧洲人中报道的不重叠。
据我们所知,这是首次在特征明确的非洲人群中对FTO基因变异进行的研究。我们的结果表明,FTO基因变异不会影响过着传统生活方式的冈比亚人的体重指标,或者其影响比在欧洲人中检测到的要小。由于研究设计和分析的差异,这些发现与先前在非裔美国人中的研究结果无法直接比较。与食物供应充足的类似种族人群相比,在几乎没有多余食物的瘦型人群中,FTO基因型对体重的任何影响可能相关性有限。